Invesco
CRBU icon

Invesco’s Caribou Biosciences CRBU Stock Holding History

Invesco’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Buy
301,117
+217,615
+261% +$430K ﹤0.01% 3215
2026
Q1 		$159K Buy
83,502
+48,439
+138% +$83.1K ﹤0.01% 3544
2025
Q4 		$55.8K Buy
35,063
+22,856
+187% +$48K ﹤0.01% 3696
2025
Q3 		$28.4K Sell
12,207
-12,532
-51% -$23.7K ﹤0.01% 3769
2025
Q2 		$31.2K Sell
24,739
-34,235
-58% -$33.7K ﹤0.01% 3747
2025
Q1 		$53.8K Sell
58,974
-6,721
-10% -$8.73K ﹤0.01% 3689
2024
Q4 		$104K Sell
65,695
-391
-0.6% -$786 ﹤0.01% 3618
2024
Q3 		$130K Sell
66,086
-1,114
-2% -$2.28K ﹤0.01% 3584
2024
Q2 		$110K Sell
67,200
-3,062
-4% -$9.79K ﹤0.01% 3739
2024
Q1 		$361K Sell
70,262
-6,767
-9% -$41.7K ﹤0.01% 3464
2023
Q4 		$441K Buy
77,029
+8,665
+13% +$42.8K ﹤0.01% 3289
2023
Q3 		$327K Buy
68,364
+2,418
+4% +$15K ﹤0.01% 3415
2023
Q2 		$280K Sell
65,946
-3,517
-5% -$15.8K ﹤0.01% 3514
2023
Q1 		$369K Buy
69,463
+47,922
+222% +$298K ﹤0.01% 3430
2022
Q4 		$135K Sell
21,541
-293,511
-93% -$2.61M ﹤0.01% 3775
2022
Q3 		$3.32M Buy
315,052
+296,643
+1,611% +$2.76M ﹤0.01% 2417
2022
Q2 		$100K Buy
18,409
+6,296
+52% +$48.1K ﹤0.01% 3887
2022
Q1 		$110K Buy
+12,113
New +$128K ﹤0.01% 3861

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco's CRBU Position: Q2 2026 in Review

Invesco increased its Caribou Biosciences (CRBU) stake by 261% in Q2 2026, buying an estimated $430K and bringing the position to 301,117 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

Invesco first reported a position in CRBU in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.32M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Invesco held 301,117 shares of Caribou Biosciences worth $530K as of Q2 2026.
  • Invesco bought 217,615 Caribou Biosciences shares in Q2 2026, an estimated $430K.
  • Caribou Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3215 holding.
  • Invesco first reported a position in Caribou Biosciences in Q1 2022 and has held it in 18 quarters since.
  • Invesco's Caribou Biosciences position peaked at $3.32M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.